Otto Dueno, MD
Psychiatry · Dayton, OHNPI 1467447623
Payments from drug & device makers
Across 1,253 payments — averaging $2472.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$540K
- Sage Therapeutics, LLC$526K
- Sunovion Pharmaceuticals Inc.$407K
- Hoffmann-la Roche Limited$225K
- Janssen Research & Development, LLC$224K
- Indivior Inc.$197K
- plus $978K from 36 others
Across 2 payments — averaging $2437.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orexo US, Inc.$5K
What the payments were for
- Consulting fees$6,9389%
- Speaking & faculty fees$54,84574%
- Travel & lodging$2,9534%
- Food & beverage$9,74113%
- Education$170%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$42,133
- SPRAVATO$19,720
- INVEGA TRINZA$3,442
- INVEGA SUSTENNA$3,340
- NEUROSTAR TMS THERAPY$128
- Jornay PM 20mg capsules (Bottle of 100)$125
How this compares
$3,098,279 in reported general payments places this provider in the 95th percentile of 1,119 psychiatry providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CaplytaLumateperone Tosylate | 53 | $84,375 |
| AuvelityDextromethorphan Hbr/Bupropion | 50 | $45,596 |
| TrintellixVortioxetine Hydrobromide | 32 | $23,494 |
| VraylarCariprazine Hcl | 18 | $23,026 |
| RexultiBrexpiprazole | 12 | $15,713 |
| Paliperidone ErPaliperidone | 25 | $13,843 |
| Aripiprazole | 152 | $8,204 |
| Lurasidone Hcl | 46 | $6,884 |
| Ziprasidone Hcl | 12 | $6,147 |
| Clozapine | 68 | $5,104 |
| Asenapine Maleate | 19 | $5,103 |
| Duloxetine Hcl | 134 | $4,565 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 59 | $4,216 |
| Clonazepam | 313 | $3,563 |
| Divalproex Sodium ErDivalproex Sodium | 36 | $3,128 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $116,396 | $84,37553 claims |
| Axsome Therapeutics, Inc.Auvelity | $630 | $45,59650 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $301 | $23,49432 claims |
| AbbVieVraylar | $540,335 | $23,02618 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $1,043 | $15,71312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,119 psychiatry providers in Ohio.
Other psychiatry in Dayton
- Amita PatelDayton$2.1M
- Richard SandersDayton$1.8M
- Darshan SehbiDayton$137K
- Shishuka MalhotraCanton$15M
- Henry NasrallahCincinnati$3.8M
- Diab AlmhanaAvon Lake$2.7M
- Mohamed Abdel AzizWest Chester$2.6M
- Fred RomeoColumbus$2.3M
- Mark WoyshvilleMiddleburg Heights$2.2M
- Caleb AdlerCincinnati$2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.